Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial

Publication Date

2-14-2023

Content Type

Article

PubMed ID:

35849035

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Plum Print visual indicator of research metrics
PlumX Metrics
  • Usage
    • Abstract Views: 11
see details

Share

COinS